Back to search results

A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa

Abroad (travel likely)Recruiting

Conditions

Advanced Parkinson's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Hospital Regional Universitario de Malaga /ID# 276357, Málaga, Andalusia, Spain

  • Hospital Universitari Son Espases /ID# 276349, Palma, Balearic Islands, Spain

  • Hospital Germans Trias i Pujol /ID# 280865, Badalona, Barcelona, Spain

  • Hospital Universitario Marques de Valdecilla /ID# 276315, Santander, Cantabria, Spain

  • Hospital General Universitario Santa Lucía /ID# 277222, Cartagena, Murcia, Spain

  • Hospital de Cabuenes /ID# 276314, Gijón, Principality of Asturias, Spain

  • Hospital Universitario Virgen del Rocio /ID# 277806, Seville, Sevilla, Spain

  • Hospital Universitario Torrecárdenas /ID# 276899, Almería, Spain

  • Hospital Universitario Vall de Hebron /ID# 276318, Barcelona, Spain

  • Hospital Santa Creu i Sant Pau /ID# 276319, Barcelona, Spain

  • Hospital Universitario De Burgos /ID# 276317, Burgos, Spain

  • Hospital De Santa Caterina /ID# 280913, Girona, Spain

  • Hospital Universitario Virgen de las Nieves /ID# 276350, Granada, Spain

  • Hospital Universitario Clinico San Cecilio /ID# 276356, Granada, Spain

  • Complejo Hospitalario Universitario de Pontevedra /ID# 276313, Pontevedra, Spain

  • Hospital Universitario De Toledo /ID# 276884, Toledo, Spain

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)